Position in XERS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$714,467
-$252,527 QoQ
Shares Held
123,184
0.0% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GLOBEFLEX CAPITAL L P holds $35,758,711 across 12 Drug Manufacturers - Specialty & Generic names. XERS ranks #11 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PAHC |
Phibro Animal Health Corp
|
210,039 | $11,617,257 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
84,145 | $6,470,750 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
93,396 | $4,497,017 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
28,173 | $3,711,511 | |
| 5 | EBS |
Emergent BioSolutions Inc.
|
241,298 | $2,002,773 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
146,303 | $1,818,546 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
52,955 | $1,751,221 | |
| 8 | ANIK |
Anika Therapeutics, Inc.
|
87,600 | $1,270,200 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $714,467 | 123,184 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $966,994 | 123,184 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,002,717 | 123,184 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $375,612 | 80,431 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $687,402 | 125,210 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $424,461 | 125,210 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||